3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Sexual Dysfunction, Physiological
1
Non-Small Cell Lung Cancer ALK-positive
1
Neuroblastoma
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Lung Neoplasms
1
Lung Diseases
1
Hyperlipidemias
1
Eunuchism
1
Erectile Dysfunction
1
Brain Neoplasms
1
ALK-positive Non-small Cell Lung Cancer
1
ALK-positive NSCLC
1
Interventions
Blood Specimen Collection
7
Drug Therapy
6
Surveys and Questionnaires
5
Radiotherapy
5
Radiosurgery
5
Docetaxel
5
Therapeutics
4
Specimen Handling
4
Immunotherapy
4
Hepatectomy
4
exemestane
3
enzalutamide
3
apalutamide
3
Trastuzumab
3
Hematologic Tests
3
Data Collection
3
Biopsy
3
Biological Assay
3
Anastrozole
3
Abiraterone Acetate
3
trastuzumab deruxtecan
2
palbociclib
2
darolutamide
2
abiraterone
2
abemaciclib
2
Wearable Electronic Devices
2
Triptorelin Pamoate
2
Tamoxifen
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasm Metastasis
×
lorlatinib
×
Clear all
NCT05167500
2023-03-30
LORLAPULM
Fundación GECP
Completed
118 enrolled